FDA May Toughen the Regulations for Transvaginal Mesh Devices

Ennis & Ennis, P.A. Summarizes the Executive Report Issued by The FDA Regarding Surgical Mesh for Treatment of Women With Pelvic Organ Prolapse and Stress Urinary Incontinence (PRWEB) September 03, 2011 Ennis & Ennis, P.A. reports that the U.S. Food and Drug Administration (FDA) is considering regulatory changes to the classification of surgical mesh devices used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). According to the FDA Executive Summary released yesterday, the FDA believes that “vaginal placement of surgical mesh for pelvic organ prolapse re
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations